Stop allergy and inflammation before they start

    loading  Checking for direct PDF access through Ovid

Abstract

An antiallergy treatment that may improve upon antihistamines is under development at the Austin Research Institute in Melbourne, Australia. Two distinct recombinant cell receptors capable of intervening in the disease processes of allergy and inflammation have been produced. Preclinical testing has been completed with encouraging results. Now, a commercial partner is needed to help move these Fc receptors from the benchtop to the bedside.Inpharmaspoke with Dr Mark Hogarth, a senior research fellow for the National Health and Medical Research Council, to find out more.

Related Topics

    loading  Loading Related Articles